Distinct scavenger receptor expression and function in the human CD14+/CD16+ monocyte subset

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 4 45-4, 1999, Pages

  Draude, Georg ^a   Von Hundelshausen, Philipp ^a   Frankenberger, Marion ^b   Ziegler Heitbrock, H W Löms ^b   Weber, Christian ^a,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Inst Prophylaxe K   (Germany)

Author keywords

Atherogenesis; Monocytes; Oxidized low density lipoproteins; Scavenger receptors

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032958364     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.4.h1144     Document Type: Article

References (41)

1. Arenson, E. B. J., M. B. Epstein, and R. C. Seeger. Volumetric and functional heterogeneity of human monocytes. J. Clin. Invest. 65: 613-618, 1980.
2. Beekhiuzen, H., and R. van Furth. Monocyte adherence to human vascular endothelium. J. Leukoc. Biol. 54: 363-378, 1993.
3. + monocytes in human sepsis: a case report of a patient with self-induced septicemia. Shock 8: 73-75, 1997.
4. Bottalico, L. A., R. E. Wager, L. B. Agellon, R. K. Assosian, and I. Tabas. Transforming growth factor-β1 inhibits scavenger receptor activity in THP-1 human macrophages. J. Biol. Chem. 266: 22866-22871, 1991.
5. De Villiers, W. J., I. P. Fraser, D. A. Hughes, A. G. Doyle, and S. Gordon. Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J. Exp. Med. 180: 705-709, 1994.
6. Draude, G., N. Hrboticky, and R. L. Lorenz. The lectin-like oxidized low density lipoprotein receptor is expressed on human vascular smooth muscle cells and monocytes and is down-regulated by lovastatin. Biochem. Pharmacol. In press.
7. Erl, W., P. C. Weber, and C. Weber. Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands. Atherosclerosis 136: 297-303, 1998.
8. + blood monocytes is expanded in sepsis patients. Blood 82: 3170-3176, 1993.
9. Frankenberger, M., T. Sternsdorf, H. Pechumer, A. Pforte, and H. W. L. Ziegler-Heitbrock. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 87: 373-377, 1996.
10. Freeman, M. W. Scavenger receptors in atherosclerosis. Curr. Opin. Hematol. 4: 41-47, 1997.
11. Geng, Y., T. Kodama, and G. K. Hansson. Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler. Thromb. 14: 798-806, 1994.
12. Geng, Y. J., and G. K. Hansson. Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 89: 1322-1330, 1992.
13. Haworth, R., N. Platt, S. Keshav, D. Hughes, E. Darley, H. Suzuki, Y. Kurihara, T. Kodama, and S. Gordon. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J. Exp. Med. 186: 1431-1439, 1997.
14. Hsu, H. Y., A. C. Nicholson, and D. P. Hajjar. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-α is transcriptionally and post-transcriptionally regulated. J. Biol. Chem. 271: 7767-7773, 1996.
15. Huh, H. Y., S. F. Pearce, L. M. Yesner, J. L. Schindler, and R. L. Silverstein. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 87: 2020-2028, 1996.
16. Locher, C., G. Vanham, L. Kestens, M. Kruger, J. L. Ceuppens, J. Vingerhoets, and P. Gigase. Expression patterns of Fcγ receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals. Clin. Exp. Immunol. 98: 115-122, 1994.
17. Nishimura, N., M. Harada-Shiba, S. Tajima, R. Sugano, T. Yamamura, Q. Z. Qiang, and A. Yamamoto. Acquisition of secretion of transforming growth factor-β1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line, THP-1. J. Biol. Chem. 273: 1562-1567, 1998.
18. Nozaki, S., H. Kashiwagi, S. Yamashita, T. Nakagawa, B. Kostner, Y. Tomiyama, A. Nakata, M. Ishigami, J. Miyagawa, K. Kameda-Takemura, Y. Kurata, and Y. Matsuzawa. Reduced uptake of oxidized low density lipoprotein in monocyte-derived macrophages from CD36-deficient subjects. J. Clin. Invest. 96: 1859-1865, 1995.
19. Passlick, B., D. Flieger, and H. W. L. Ziegler-Heitbrock. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74: 2527-2534, 1989.
20. Pietsch, A., W. Erl, and R. L. Lorenz. Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells. Biochem. Pharmacol. 52: 433-439, 1996.
21. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
22. Rothe, G., H. Gabriel, E. Kovacs, J. Klucken, J. Stohr, W. Kindermann, and G. Schmitz. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler. Thromb. Vase. Biol. 16: 1437-1447, 1996.
23. Sawamura, T., N. Kume, T. Aoyama, H. Moriwaki, Y. Aiba, T. Tanaka, S. Miwa, Y. Katsura, T. Kita, and T. Masaki. An endothelial receptor for oxidized low-density lipoprotein. Nature 386: 73-77, 1997.
24. Scheithe, R., A. K. Heidenthal, U. Danesch, E. Mauthner, G. Hapfelmeier, A. Becker, A. Pietsch, P. C. Weber, and N. Hrboticky. Acetylated LDL endocytosis by the human monocytic Mono Mac 6sr cells is not mediated by the macrophage type I and II scavenger receptors. Arterioscler. Thromb. Vasc. Biol. 17: 1024-1031, 1997.
25. Schmitz, G., E. Orsó, G. Rothe, and J. Klucken. Scavenging, signalling and adhesion coupling in macrophages: implication for atherogenesis. Curr. Opin. Lipidol. 8: 287-300, 1997.
26. Sica, A., A. Saccani, A. Borsatti, C. A. Power, T. N. Wells, W. Luini, N. Polentarutti, S. Sozzani, and A. Mantovani. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 185: 969-974, 1997.
27. Tangirala, R. K., K. Murao, and O. Quehenberger. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines. J. Biol. Chem. 272: 8050-8056, 1997.
28. Teupser, D., J. Thiery, A. K. Walli, and D. Seidel. Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. Biochim. Biophys. Acta 1303: 193-198, 1996.
29. Van der Kooij, M. A., O. H. Morand, H. J. Kempen, and T. J. van Berkel. Decrease in scavenger receptor expression in human monocyte-derived macrophages treated with granulocyte macrophage colony-stimulating factor. Arterioscler. Thromb. Vasc. Biol. 16: 106-114, 1996.
30. Van Lenten, B. J., and A. M. Fogelman. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-α. J. Immunol. 148: 112-116, 1992.
31. Weber, C., R. Alon, B. Moser, and T. A. Springer. Sequential regulation of α4β1 and α5β1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J. Cell Biol. 134: 1063-1073, 1996.
32. Weber, C., W. Erl, A. Pietsch, M. Ströbel, H. W. L. Ziegler-Heitbrock, and P. C. Weber. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler. Thromb. 14: 1665-1673, 1994.
33. Weber, C., W. Erl, A. Pietsch, and P. C. Weber. Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 91: 1914-1917, 1995.
34. Weber, C., C. F. Lu, J. M. Casasnovas, and T. A. Springer. Role of αLβ2 integrin avidity in transendothelial chemotaxis of mononuclear cells. J. Immunol. 159: 3968-3975, 1997.
35. Weber, C., E. Negrescu, W. Erl, A. Pietsch, M. Frankenberger, H. W. Ziegler-Heitbrock, W. Siess, and P. C. Weber. Inhibitors of protein tyrosine kinase suppress TNF-α stimulated induction of endothelial cell adhesion molecules. J. Immunol. 155: 445-451, 1995.
36. Yasaka, T., N. M. Mantich, L. A. Boxer, and R. L. Baehner. Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. Eur. J. Immunol. 127: 1515-1518, 1981.
37. Yesner, L. M., H. Y. Huh, S. F. Pearce, and R. L. Silverstein. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler. Thromb. Vasc. Biol. 16: 1019-1025, 1996.
38. Ylä-Herttuala, S., B. A. Lipton, M. E. Rosenfeld, T. Sarkioja, T. Yoshimura, E. J. Leonard, J. L. Witztum, and D. Steinberg. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 88: 5252-5256, 1991.
39. + subpopulation. Immunol. Today 17: 424-428, 1996.
40. + blood monocytes exhibits features of tissue macrophages. Eur. J. Immunol. 23: 2053-2058, 1993.
41. Ziegler-Heitbrock, H. W. L., B. Passlick, and D. Flieger. The monoclonal antimonocyte antibody My4 stains B lymphocytes and two distinct monocyte subsets in human peripheral blood. Hybridoma 7: 521-527, 1988.